相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
Soren Weidemann et al.
BIOMEDICINES (2021)
Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma
Christine Alewine et al.
CLINICAL CANCER RESEARCH (2020)
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors
Raffit Hassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin
Raffit Hassan et al.
CANCER (2020)
Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategies
Valeska Moentenich et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Mesothelin expression and its prognostic role according to microsatellite instability status in colorectal adenocarcinoma
Hyunsung Kim et al.
MEDICINE (2019)
Mesothelin as a target for cervical cancer therapy
Korinna Joehrens et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group
Atsumi Kojima et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models
Maria Quanz et al.
Oncotarget (2018)
Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative Zr-89-ImmunoPET
Anton G. T. Terwisscha van Scheltinga et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy
Tatsuya Hanaoka et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
Stergios Boussios et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
Raffit Hassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
Ryo Kitagawa et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis
Anish Thomas et al.
ONCOTARGET (2015)
Mesothelin expression is associated with poor outcomes in breast cancer
Yun R. Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma
Stefan S. Kachala et al.
CLINICAL CANCER RESEARCH (2014)
HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases
Edyta C. Pirog et al.
MODERN PATHOLOGY (2014)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival
Gary Tozbikian et al.
PLOS ONE (2014)
Mesothelin Expression Is a Prognostic Factor in Cholangiocellular Carcinoma
Ryohei Nomura et al.
INTERNATIONAL SURGERY (2013)
Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma
Atsushi Shimizu et al.
CANCER SCIENCE (2012)
Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients
Elliot L. Servais et al.
CLINICAL CANCER RESEARCH (2012)
Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: Adenocarcinoma versus squamous cell carcinoma
Seiji Mabuchi et al.
GYNECOLOGIC ONCOLOGY (2012)
Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer
Futoshi Kawamata et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study
Freddie Bray et al.
LANCET ONCOLOGY (2012)
A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
Jordan M. Winter et al.
PLOS ONE (2012)
High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
W-F Cheng et al.
BRITISH JOURNAL OF CANCER (2009)
Revised FIGO staging for carcinoma of the cervix
Sergio Pecorelli et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
Mesothelin expression in human lung cancer
Mitchell Ho et al.
CLINICAL CANCER RESEARCH (2007)
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - A 24-year population-based study
HO Smith et al.
GYNECOLOGIC ONCOLOGY (2000)
分享论文
